The Journal of clinical psychiatry

(ISSN: 0160-6689, 1555-2101)

Table of Contents

2016 - 77 (5)

  • Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression. 
  • Age at the time of exposure to trauma modulates the psychopathological profile in patients with early psychosis. 
  • Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. 
  • Impact of anxious symptoms and comorbid anxiety disorders on functional impairment in depressed patients. 
  • Why is mechanism of action important in antidepressant treatment? 
  • Sudden cardiac death related to antipsychotics: beyond the long QT syndrome hypothesis. 
  • Gene expression profiling of the xMHC region reveals 9 candidate genes in schizophrenia. 
  • How many treatments before clozapine? medication choices across the spectrum of treatment resistance in schizophrenia. 
  • Benzodiazepine safety: mortality risk or multiple chronic disease comorbidity? 
  • The incidence of seizures with antipsychotics. 
  • Can development of PTSD be prevented after acute trauma? 
  • Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders. 
  • Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. 
  • Cannabis and neuropsychiatry, 1: benefits and risks. 
  • Safety and efficacy of electroconvulsive therapy for depression in the presence of deep brain stimulation in obsessive-compulsive disorder. 
  • Open-Label trial on the effects of memantine in adults with obsessive-compulsive disorder after a single ketamine infusion. 
  • Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study. 
  • The course of suicide risk following traumatic injury. 
  • Quantifying intraindividual variations in plasma clozapine levels: a population pharmacokinetic approach. 
  • Adherence to antidepressants is associated with lower mortality: a 4-year population-based cohort study. 
  • Clinical outcomes associated with comorbid posttraumatic stress disorder among patients with bipolar disorder. 
  • Long-term outcome of early interventions to prevent posttraumatic stress disorder. 
  • Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison. 
  • Depressive symptoms following stroke and transient ischemic attack: is it time for a more intensive treatment approach? results from the TABASCO cohort study. 
  • Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study. 
  • Correlation of clinical response with homocysteine reduction during therapy with reduced B vitamins in patients with MDD who are positive for MTHFR C677T or A1298C polymorphism: a randomized, double-blind, placebo-controlled study. 
  • Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment. 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.